Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.
about
Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Prostate cancer immunotherapy, ...... munotherapy cancer resistance.
@en
Prostate cancer immunotherapy, ...... munotherapy cancer resistance.
@nl
type
label
Prostate cancer immunotherapy, ...... munotherapy cancer resistance.
@en
Prostate cancer immunotherapy, ...... munotherapy cancer resistance.
@nl
prefLabel
Prostate cancer immunotherapy, ...... munotherapy cancer resistance.
@en
Prostate cancer immunotherapy, ...... munotherapy cancer resistance.
@nl
P2860
P356
P1476
Prostate cancer immunotherapy, ...... mmunotherapy cancer resistance
@en
P2093
P2860
P304
P356
10.11138/GCHIR/2016.37.5.225
P577
2017-09-01T00:00:00Z